Tìm kiếm
Amarin Corporation PLC
AMRNThêm vào danh sách theo dõi
14.260USD
+0.030+0.21%
Đóng cửa 07-31 16:00（ET）Báo giá bị trễ 15 phút
301.21MVốn hóa
LỗP/E TTM
Thêm thông tin về Amarin Corporation PLC Công ty
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Thông tin của Amarin Corporation PLC
Mã chứng khoánAMRN
Tên công tyAmarin Corporation PLC
Ngày IPOApr 01, 1993
Giám đốc điều hànhBerg (Aaron D)
Số lượng nhân viên275
Loại chứng khoánDepository Receipt
Kết thúc năm tài chínhApr 01
Địa chỉWeWork One Central Plaza Dame Street
Thành phốDUBLIN
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaIreland
Mã bưu điệnD02 K7K5
Điện thoại35316699020
Trang webhttps://amarincorp.com/
Mã chứng khoánAMRN
Ngày IPOApr 01, 1993
Giám đốc điều hànhBerg (Aaron D)
Lãnh đạo công ty của Amarin Corporation PLC
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. David Keenan, Ph.D.
Dr. David Keenan, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
235.92K
+0.75%
Dr. Paul Cohen, M.D.
Dr. Paul Cohen, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
8.46K
+5.14%
Ms. Diane E. Sullivan
Ms. Diane E. Sullivan
Non-Executive Independent Director
Non-Executive Independent Director
8.46K
+5.14%
Mr. Oliver O'Connor
Mr. Oliver O'Connor
Non-Executive Independent Director
Non-Executive Independent Director
8.42K
+4.75%
Dr. Stephen B. (Steven) Ketchum, Ph.D.
Dr. Stephen B. (Steven) Ketchum, Ph.D.
President - Research and Development, Executive Vice President, Chief Scientific Officer
President - Research and Development, Executive Vice President, Chief Scientific Officer
--
--
Mr. Aaron D. Berg
Mr. Aaron D. Berg
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Patrice Bonfiglio
Ms. Patrice Bonfiglio
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Keith L. Horn
Mr. Keith L. Horn
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Odysseas D. Kostas, M.D.
Dr. Odysseas D. Kostas, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Louis Sterling, III
Mr. Louis Sterling, III
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. David Keenan, Ph.D.
Dr. David Keenan, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
235.92K
+0.75%
Dr. Paul Cohen, M.D.
Dr. Paul Cohen, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
8.46K
+5.14%
Ms. Diane E. Sullivan
Ms. Diane E. Sullivan
Non-Executive Independent Director
Non-Executive Independent Director
8.46K
+5.14%
Mr. Oliver O'Connor
Mr. Oliver O'Connor
Non-Executive Independent Director
Non-Executive Independent Director
8.42K
+4.75%
Dr. Stephen B. (Steven) Ketchum, Ph.D.
Dr. Stephen B. (Steven) Ketchum, Ph.D.
President - Research and Development, Executive Vice President, Chief Scientific Officer
President - Research and Development, Executive Vice President, Chief Scientific Officer
--
--
Mr. Aaron D. Berg
Mr. Aaron D. Berg
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Amarin Corporation PLC?
Năm cổ đông hàng đầu của Amarin Corporation PLC là: Dr. David Keenan, Ph.D.
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Amarin Corporation PLC (AMRN)?
Tính đến ngày 2026Q1, có 280 tổ chức nắm giữ cổ phiếu của Amarin Corporation PLC, với tổng giá trị thị trường khoảng 4.71M, chiếm 22.72% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -402415.00.